Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Striational antibodies in myasthenia gravis: reactivity and possible clinical significance Romi F; Skeie GO; Gilhus NE; Aarli JAArch Neurol 2005[Mar]; 62 (3): 442-6Myasthenia gravis is an autoimmune disease caused, in most cases, by antibodies attaching to the acetylcholine receptor. Some myasthenia gravis patients have antibodies that bind in a cross-striational pattern to skeletal and heart muscle tissue sections (striational antibodies). These antibodies react with epitopes on the muscle proteins titin and ryanodine receptor, are found mainly in sera of patients with thymoma and late-onset myasthenia gravis, and may correlate with myasthenia gravis severity. Their presence may predict an unsatisfactory outcome after thymectomy. The detection of titin and ryanodine receptor antibodies provides more specific clinical information than the immunofluorescent demonstration of striational antibodies.|*Binding Sites, Antibody[MESH]|Autoantibodies/*metabolism[MESH]|Connectin[MESH]|Humans[MESH]|Microscopy, Fluorescence[MESH]|Muscle Proteins/immunology/metabolism[MESH]|Muscle, Skeletal/*immunology/pathology[MESH]|Myasthenia Gravis/*immunology/pathology[MESH]|Protein Kinases/immunology/metabolism[MESH]|Ryanodine Receptor Calcium Release Channel/immunology/metabolism[MESH] |